MEHA

Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June 9, 2026, it received a written notification (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. As previously disclosed, on December 30, 2025, the Company received notice from Nasdaq that the closing bid price of its common stock had been below $1.00 per share for 30 consecutive business days, and was therefore not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the "Bid Price Requirement").

Lake Oswego, Oregon--(Newsfile Corp. - June 5, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("MEHA" or the "Company") today announced advanced discussions with multiple strategic financial parties regarding the potential commercialization of the Alchemy platform's blockchain-based assets (the "BFX Assets"), a real-world asset tokenization infrastructure designed to support on-chain verification and auditability of physical gold holdings. Why Now: A Convergence of Market Forces Functional Brands Inc. believes the timing for this strategic initiative is compelling given the opportunity to utilize this IP to develop fused products which generate yield in industries where yield is not currently generated.

Highlights 51% Reduction in Current Liabilities in Q1 2026 and Posting Strongest First-Quarter Gross Profit on Record Lake Oswego, Oregon--(Newsfile Corp. - June 4, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a U.S.-domiciled Nasdaq issuer, which is party to a binding agreement to acquire the assets of BullionFX, including its core product Alchemy — a blockchain-based settlement layer and decentralized finance ecosystem built around auditable physical gold — today provided a brief corporate and operational update on its progress toward closing the asset acquisition first announced on May 22, 2026. Vision: Where Functional Brands Is Headed — 12 to 24 Months From Now The BullionFX | Alchemy acquisition is not merely a transaction.

Shareholder vote satisfies a key closing condition Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between the Company and the close of its $142.9 million acquisition of BullionFX | Alchemy, a gold-backed decentralized finance platform targeting retail, institutional, and blockchain markets. The Company's focus now shifts to closing the acquisition.

Definitive agreement signed; management communicates rationale targeting activation in Q3 2026; gold-backed DeFi platform designed to deliver above-market yield on physical gold positions - compared to near 0% for traditional gold ETFs. Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the acquisition of assets from BullionFX, including its Alchemy technology platform; a vertically integrated, gold-backed blockchain settlement layer and decentralized finance (DeFi) ecosystem targeting retail, institutional, and blockchain markets (the "Acquired Assets").

Lake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Revenue grew to $1.65 million, up 3.5% from $1.59 million in the prior year period, reflecting continued momentum across the Company's brand portfolio.

Lake Oswego, Oregon--(Newsfile Corp. - May 12, 2026) - Functional Brands Inc. (NASDAQ: MEHA), (the "Company"), a leading innovator in wellness and performance products, today announced that it has entered into a Conversion Price Reduction and Waiver Agreement with all holders of the Company's Series C Convertible Preferred Stock. Under the terms of the Agreement, the conversion price applicable to the Series C Preferred Stock during the Fixed Conversion Period has been modified to $0.1636 per share of common stock, reflecting the current market price at the time of execution.

Strategic acquisition of BullionFX | Alchemy assets is expected to position MEHA to develop a decentralized gold-backed financial ecosystem anchored by an auditable physical gold infrastructure Lake Oswego, Oregon--(Newsfile Corp. - May 11, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, today announced it has executed a binding Letter of Intent ("LOI") to acquire the assets of BullionFX, including its core product Alchemy (collectively, the "BullionFX Assets"), in an all-stock transaction valued at approximately $142.9 million. The transaction contemplated by the LOI represents a strategic asset acquisition that is expected to provide the Company with access to technology, infrastructure and intellectual property associated with the BullionFX Assets, a blockchain-based financial ecosystem designed around auditable physical gold.

Proprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health Platform Lake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a pioneer in next-generation health and wellness solutions, today announced the official launch of GLP-Squared Injection, its groundbreaking dual-peptide injectable combining Semaglutide and Tirzepatide in a single, synergistic formulation. GLP-Squared is now exclusively available to members of the Company's flagship digital health platform, Tru2u.health.

Lake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a significant expansion of its digital health platform, www.Tru2u.health, with the addition of NAD+ (Nicotinamide Adenine Dinucleotide) therapy. This milestone enhances Tru2u.health's already comprehensive suite of solutions that includes peptide protocols, GLP-1-based weight management, and board-certified telehealth support.